Please ensure Javascript is enabled for purposes of website accessibility

Penn State Health to acquire hematology and oncology practice

AndrewsPatel Hematology/Oncology is planning to join Penn State Health later this year.

The Penn State Health board of directors approved the agreement earlier this month, according to a press release issued Wednesday by the Derry Township-based health system. AndrewsPatel board of directors approved the agreement last week. The financial terms were not disclosed.

Under agreement between the two organizations, which could take effect as early as Sept. 1, 90 AndrewsPatel employees, including 10 physicians, will become Penn State Health employees.

“We’re excited to become part of a local network with Penn State Health because it will offer patients a full spectrum of services, including access to clinical trials, without leaving the region for care,” Dr. Kathryn Peroutka, president of AndrewsPatel, said in a statement.

AndrewsPatel operates two outpatient sites – one in Lower Paxton Township and another in Hampden Township. It also provides inpatient cancer services at UPMC Pinnacle in Harrisburg and Geisinger Holy Spirit in East Pennsboro Township. The practice will continue to work with both hospitals after the merger, AndrewPatel spokesperson, Azlynn Swartz said.

Specialists at Penn State Cancer Institute, based at the Penn State Health Milton S. Hershey Medical Center in Derry Township, treat every type of cancer.

Penn State Health Medical Group, which includes all physicians and providers in Penn State Health involved in clinical care, has over 1,200 providers. 

In addition to Penn State Cancer Institute and AndrewPatel, the Penn State Health cancer network includes Penn State Heath St. Joseph Cancer Center in Berns Township, Berks County and Penn State Health Medical Group – Lancaster Hematology Oncology in Lancaster.

“Penn State Health and Andrews Patel share a vision for providing the most cutting edge cancer care, from diagnosis, treatment and survivorship to the eventual eradication of this disease through prevention and cure,” Dr. Craig Hillemeier, dean of Penn State College of Medicine, CEO of Penn State Health and senior vice president for health affairs at Penn State, said in a statement.

Business Events

Health Care Update Webinar

Wednesday, May 25, 2022
Health Care Update Webinar

Highmark Webinar

Wednesday, June 08, 2022
Highmark Webinar

Women of Influence

Thursday, June 30, 2022
Women of Influence